(Q51807688)

12 April 2018

title

Electrocardiographic response to enzyme replacement therapy for Pompe disease. (English)

1 reference

12 April 2018

enzyme replacement therapy

main subject

0 references

1 reference

Annette K Ansong

1

1 reference

12 April 2018

Jennifer S Li

2

1 reference

12 April 2018

Eva Nozik-Grayck

3

1 reference

12 April 2018

Richard Ing

4

1 reference

12 April 2018

Richard M Kravitz

5

1 reference

12 April 2018

Salim F Idriss

6

1 reference

12 April 2018

Ronald J Kanter

7

1 reference

12 April 2018

Henry Rice

8

1 reference

12 April 2018

Y T Chen

9

1 reference

12 April 2018

Priya S Kishnani

10

1 reference

12 April 2018

language of work or name

English

0 references

publication date

1 May 2006

1 reference

12 April 2018

published in

Genetics in Medicine

1 reference

12 April 2018

volume

8

1 reference

12 April 2018

issue

5

1 reference

12 April 2018

page(s)

297-301

1 reference

12 April 2018

https://scigraph.springernature.com/pub.10.1097/01.gim.0000195896.04069.5f

exact match

0 references

cites work

Pompe disease in infants and children

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000195896.04069.5F

The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000195896.04069.5F

Pompe's disease presenting as hypertrophic myocardiopathy with Wolff-Parkinson-White syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000195896.04069.5F

Safety and efficacy of recombinant acid alpha-glucosidase (rhGAA) in patients with classical infantile Pompe disease: results of a phase II clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000195896.04069.5F

Recombinant human alpha-glucosidase from rabbit milk in Pompe patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000195896.04069.5F

Anatomic validation of left ventricular mass estimates from clinical two-dimensional echocardiography: initial results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000195896.04069.5F

Glycogen storage diseases presenting as hypertrophic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000195896.04069.5F

Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000195896.04069.5F

Danon's disease as a cause of hypertrophic cardiomyopathy: a systematic survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000195896.04069.5F

Generalized glycogen storage and cardiomegaly in a knockout mouse model of Pompe disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000195896.04069.5F

Targeted disruption of the acid alpha-glucosidase gene in mice causes an illness with critical features of both infantile and adult human glycogen storage disease type II

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000195896.04069.5F

Echocardiographic abnormalities and disease severity in Fabry's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000195896.04069.5F

Measurement, interpretation and clinical potential of QT dispersion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000195896.04069.5F

QT dispersion and risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000195896.04069.5F

Inducible polymorphic ventricular tachycardia and ventricular fibrillation in a subgroup of patients with hypertrophic cardiomyopathy at high risk for sudden death

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000195896.04069.5F

Towards a molecular therapy for glycogen storage disease type II (Pompe disease).

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000195896.04069.5F

10.1097/01.GIM.0000195896.04069.5F

21 January 2018

Identifiers

DOI

1 reference

12 April 2018

Dimensions Publication ID

0 references

1 reference

12 April 2018